| Course | N508 Theory and Research |
|---|---|
| Module | Module 3 |
| Paper type | Epidemiology research paper |
| Length | About 1,483 words, 8 pages |
| Format | APA 7 student paper |
| School | Aspen University |
| Program | MSN |
| Updated | October 2026 |
Free sample paper for N508 Module 3
From Counting Cases to Testing Causes: An Emerging Infectious Diseases Study, Descriptive and Analytic Epidemiology, and the Protection of Participants
Student Name
Master of Science in Nursing Program, Aspen University
N508: Theory and Research
Instructor Name
Month Day, Year
From Counting Cases to Testing Causes: An Emerging Infectious Diseases Study, Descriptive and Analytic Epidemiology, and the Protection of Participants
Epidemiology is the study of how disease is distributed in populations and what determines that distribution. Its designs range from descriptive studies that count and characterize cases to analytic studies that test hypotheses about causes. Nurses use both kinds of evidence, often without naming them, when they read an outbreak report or a study of risk factors. This paper analyzes a descriptive study published in the Centers for Disease Control and Prevention's journal Emerging Infectious Diseases, contrasts it with an analytic case-control study from the same journal, and reviews how research participants are protected in epidemiologic work, where consent is often impractical.
The Descriptive Study: Candida auris Hospitalizations
Candida auris is a multidrug-resistant yeast that spreads in health care facilities and can cause invasive infections with high mortality. Benedict et al. (2023) used a large U.S. hospital discharge database to describe hospitalizations associated with C. auris from 2017 through 2022. They identified 192 such hospitalizations, 38 of them (20 percent) involving bloodstream infections. Patients had extensive concurrent medical conditions and heavy prior health care use, and the estimated crude mortality rate was 34 percent. The authors concluded that the findings support continued surveillance and containment efforts.
The study is descriptive: it characterizes who was affected, where, and with what outcomes, without testing a hypothesis about causes. Its strengths are its national scope and its use of a large database that captures clinical detail, and it answers practical questions for infection preventionists and nurses, such as what kinds of patients are affected and how often infection invades the bloodstream. Its limitations are those of descriptive designs. With no comparison group, it cannot show which characteristics increase the risk of C. auris; a database of participating hospitals may not represent all U.S. hospitals; and crude mortality reflects patients' severe underlying illness as well as the infection itself, so it cannot be read as the death rate caused by C. auris. A descriptive study tells nurses what the problem looks like; it cannot tell them what causes it.
The Analytic Study: Risk Factors for Hospitalization With Pandemic Influenza
Analytic epidemiology tests hypotheses by comparing groups. Ward et al. (2011) conducted a case-control study in Sydney, Australia, during the 2009 influenza pandemic to identify risk factors for hospitalization with pandemic H1N1 infection among people older than 16 years. They compared 302 case-patients who were hospitalized with 603 controls from the community and used logistic regression, adjusting for age and sex. Pregnancy was the strongest risk factor, with an odds ratio of 22.4, followed by pre-existing lung disease, immune suppression, asthma requiring regular preventive medication, diabetes, heart disease, and current or former smoking. Obesity was not independently associated with hospitalization but was associated with requiring mechanical ventilation.
The case-control design is efficient for identifying risk factors, especially when an outcome is uncommon, because investigators start with people who have the outcome and look back at their exposures. Its strengths here include a clear case definition, a control group twice the size of the case group, and adjustment for confounding by age and sex. Its limitations include possible recall bias, since exposures were reported after the fact, and the difficulty of choosing controls who represent the population that produced the cases. Odds ratios estimate association, not proof of cause, although a very large odds ratio such as the one for pregnancy, consistent with other studies, strongly suggests a real effect.
The Measures Each Study Uses
The two studies also rely on different measures, and reading them correctly is part of appraisal. Descriptive studies report frequencies and proportions. The C. auris study reports a count of hospitalizations, the proportion with bloodstream infection, and a crude mortality rate, the share of patients who died without adjustment for their other conditions. Such measures describe burden but carry no comparison, so they cannot say whether C. auris patients die more often than similar patients without the infection.
Analytic studies report measures of association. A case-control study reports odds ratios, which compare the odds of an exposure among cases with the odds among controls. An odds ratio of 1 means no association; values above 1 suggest the exposure is more common among cases. The 95 percent confidence interval shows the precision of the estimate: the interval for pregnancy, 9.2 to 54.5, is wide because relatively few participants were pregnant, but it lies far above 1, so the association is unlikely to be due to chance. Cohort studies, by contrast, follow exposed and unexposed groups forward and report relative risks, which are easier to interpret but require much larger or longer studies for uncommon outcomes.
Adjustment is the final concept. Because older people are more likely both to have chronic diseases and to be hospitalized, an unadjusted association between heart disease and hospitalization could simply reflect age. Ward et al. (2011) adjusted for age and sex to reduce that confounding, although factors they did not measure could still play a role.
Comparing the Two Designs
The two studies answer different questions and belong at different points in the investigation of a disease. Descriptive studies come first. They define the problem, generate hypotheses, and guide resource allocation: the C. auris study tells hospitals that affected patients are severely ill and heavily exposed to health care, which suggests where to focus screening. Analytic studies follow, testing whether suspected factors actually increase risk: the influenza study turned the hypothesis that pregnancy and chronic disease increase risk into estimates that guided vaccination priorities. In evidence hierarchies, descriptive studies rank lower than analytic studies because they cannot test causation, but that ranking understates their value; without careful counting, analytic studies would have nothing to test.
For nursing practice, the distinction guides how evidence is used. A nurse reading the C. auris report should use it to understand the burden and to advocate for surveillance and infection control, not to conclude that any particular patient characteristic causes infection. A nurse reading the influenza case-control study can use it to prioritize patient education and vaccination for pregnant patients and those with chronic lung disease, while recognizing that it shows association within one population.
Protecting Research Participants
Epidemiologic research often uses data about people who never agreed to be studied: hospital records, surveillance reports, and databases. The ethical principles that govern research with human participants still apply. The Belmont Report established three principles, respect for persons, beneficence, and justice, expressed through informed consent, assessment of risks and benefits, and fair selection of participants (National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979). Federal regulations based on those principles require institutional review board oversight of most research with human subjects and allow a board to waive individual consent when three conditions hold: the research poses no more than minimal risk, it would be impracticable to do it any other way, and waiving consent will not harm participants' rights or welfare.
The two studies illustrate different protections. Research using a large, de-identified hospital database, like the C. auris study, poses minimal risk and relies on removal of identifiers and data use agreements rather than individual consent. The influenza case-control study involved interviewing case-patients and controls, so participants were asked for consent and told how their information would be used. Public health surveillance and outbreak investigations conducted by health authorities under their legal mandate are generally treated differently from research, but when their data are later used for research, the same principles of privacy, minimal risk, and oversight apply. For nurses who conduct or assist with epidemiologic research, the key recommendations are to consult the institutional review board early, collect only the data needed, protect identifiers, and respect participants' right to decline when consent is sought.
Justice deserves particular attention in infectious disease research. Outbreaks often fall hardest on people in nursing homes, prisons, crowded housing, or low-wage jobs, who may be studied intensively during a crisis and then see little benefit afterward. Fair research in these settings means involving affected communities in how findings are shared, avoiding language that stigmatizes groups linked to an outbreak, and ensuring that the knowledge gained, such as better screening or vaccination priorities, reaches the populations that made the research possible.
Conclusion
The Candida auris study and the pandemic influenza study show epidemiology's two main modes. The first describes a new threat, revealing a severely ill, heavily treated population with high crude mortality, and the second tests which factors raise risk, identifying pregnancy and chronic disease as strong predictors of hospitalization. Each has strengths and limits that a nurse must understand to apply its findings correctly. Both depend on the trust of the people whose data make them possible, which is why the principles of respect, beneficence, and justice, and the oversight that puts them into practice, remain essential even when individual consent is not.
References
Benedict, K., Forsberg, K., Gold, J. A. W., Baggs, J., & Lyman, M. (2023). Candida auris-associated hospitalizations, United States, 2017-2022. Emerging Infectious Diseases, 29(7), 1485-1487. https://doi.org/10.3201/eid2907.230540
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont report: Ethical principles and guidelines for the protection of human subjects of research. U.S. Department of Health, Education, and Welfare.
Ward, K. A., Spokes, P. J., & McAnulty, J. M. (2011). Case-control study of risk factors for hospitalization caused by pandemic (H1N1) 2009. Emerging Infectious Diseases, 17(8), 1409-1416. https://doi.org/10.3201/eid1708.100842
N508 Module 3 instructions, in plain terms
Aspen's N508 Module 3 has you analyze, in roughly 1,500 words or more, a study from the CDC journal Emerging Infectious Diseases and comparing descriptive and analytic epidemiology, with attention to protecting participants. Check the classroom for required study sources. Summarize each study's question, design and findings. Classify each as descriptive or analytic and explain why. Interpret the measures each reports correctly, including adjusted results. Compare when each design is used. Address how participants' rights are protected, especially in research using records or surveillance data. Close with what the designs mean for nursing practice, so the reader sees why a graduate nurse needs to tell the two kinds of study apart.
How this N508 Module 3 example is built
The introduction defines epidemiology as the study of how disease is distributed and what determines it. The descriptive section summarizes the Candida auris study, its data source and what it found about patients and outcomes, and explains why it is descriptive. The analytic section summarizes Ward's case-control study and explains why the design suits uncommon outcomes. The measures section contrasts rates and proportions with odds ratios and explains adjustment for confounding. The comparison section places the designs at different points in investigating a disease and explains how nurses should use each kind of evidence. The protection section explains waivers of consent for records research, applies the Belmont principles and gives justice particular attention in infectious disease work. The conclusion summarizes the two modes of epidemiology.
Reading the N508 Module 3 grading rubric
Epidemiology papers are judged by accurate summaries, correct classification, interpretation of measures, comparison of designs, participant protection and APA writing. Credit for the classification row comes from explaining why each study is descriptive or analytic. Measures are interpreted correctly, including adjustment. Protection is addressed with the Belmont Report and the conditions for waiving consent. Benedict and colleagues' 2023 Emerging Infectious Diseases study, the Belmont Report of 1979 and Ward, Spokes and McAnulty's 2011 case-control study make up the N508 reference list. The comparison links designs to their uses, which shows understanding beyond definitions. The nursing use of each design is stated plainly, so the comparison does not stay at the level of textbook terms.
Common N508 Module 3 mistakes, and how to avoid them
Students often misclassify studies because they look at the topic rather than the design. Ask whether the study tests a hypothesis by comparing groups. Another problem is misreading odds ratios as risks; explain what the number means. Adjusted and unadjusted results are often confused, so state which you report. Participant protection is frequently reduced to "the study was approved by an IRB." Explain what protections applied to records research and why. Keep summaries short so analysis has room. Choose an Emerging Infectious Diseases study you can access in full. Finally, connect the designs to nursing, such as using descriptive data to plan infection prevention and analytic data to target risk factors.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Aspen University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More N508 and MSN sample papers
- N508 Module 1: Ways of Knowing Reflection
- N508 Module 2: Concept Analysis of Trust
- N508 Module 4: Sampling, Reliability and Trustworthiness
- N508 Module 5: Theory Application Paper
- N508 Module 6: Intervention and Internet Research
- N508 Module 7: NINR Priorities and Research Proposal
- N508 Module 8: Theory, Research, and Practice
- N582 Module 8: OSCE Design and Evaluation
- N520 Module 1: Ethical Issues Case Responses
- N518 Module 2: Acute and Chronic Pain
- N580 Module 7: Academic Dismissal and Due Process
N508 Module 3 questions, answered
What does N508 Module 3 usually ask for?
Commonly a paper of 1,500 to 2,000 words analyzing a CDC Emerging Infectious Diseases study, locating a descriptive and an analytic epidemiology article, and reviewing recommendations for protecting research participants, with at least three scholarly sources beyond the textbook.
What is the difference between descriptive and analytic epidemiology?
Descriptive epidemiology characterizes who has a disease, where and when, without testing causes. Analytic epidemiology compares groups, as in case-control or cohort studies, to test whether exposures increase risk. The sample uses a descriptive Candida auris study and an analytic influenza case-control study to show the difference.
When can research proceed without individual consent?
Under federal regulations, an institutional review board may waive consent when research involves minimal risk, could not practicably be done without the waiver and will not adversely affect participants' rights and welfare. Large de-identified database studies often qualify; studies that interview participants usually seek consent.
Where can I find a free N508 Module 3 sample paper?
You can read the whole N508 Module 3 paper above, comparing a descriptive Candida auris study with an analytic case-control study of pandemic influenza.
How do I tell descriptive from analytic epidemiology for N508 Module 3?
Descriptive studies show who, where and when without testing causes; analytic studies compare groups to test whether an exposure is linked to an outcome.